Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Oct 16, 2022
Open Peer Review Period: Oct 14, 2022 - Oct 28, 2022
Date Accepted: Dec 8, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study

Jackman KMP, Tilchin C, Duchen J, Flinn RE, Trent ME, Latkin CA, Ruhs S, Fields EL, Hamill MM, Mahaffey C, Greenbaum A, Jennings JM

Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study

JMIR Form Res 2023;7:e43550

DOI: 10.2196/43550

PMID: 36826983

PMCID: 9994643

Desires for Individual and Interpersonal Level Patient Portal Use for HIV Prevention among Urban Sexual Minority Men: A Cross-Sectional Study

  • Kevon-Mark Phillip Jackman; 
  • Carla Tilchin; 
  • Jessica Duchen; 
  • Ryan E. Flinn; 
  • Maria Eva Trent; 
  • Carl A. Latkin; 
  • Sebastian Ruhs; 
  • Errol L. Fields; 
  • Matthew M. Hamill; 
  • Carlos Mahaffey; 
  • Adena Greenbaum; 
  • Jacky M. Jennings

ABSTRACT

Background:

Gay, bisexual, and other sexual minority men (SMM) have expressed acceptability of patient portals as tools for supporting HIV prevention behaviors, including facilitating disclosure of HIV and other sexually transmitted infection (STI/HIV) laboratory test results. However, these studies, in which Black/African-American SMM were under-sampled, failed to determine the relationship of past discussion of HIV results with sex partners to anticipated willingness to disclose online STI/HIV test results using a patient portal.

Objective:

The objectives of the current study were to (a) determine preferences for patient portal use for HIV prevention and (b) test the associations between reported history of discussing HIV results and anticipated willingness to disclose online STI/HIV test results with most recent main and non-main partners using patient portals.

Methods:

Univariate and multiple logistic regression analyses were conducted on ACASI survey data among a predominantly Black/African-American sample of SMM.

Results:

Of the 245 SMM included in the sample, 71% were African-American/Black and 22% were White. Tools to help manage HIV (75%), information about pre- and post-exposure prophylaxis (both 71%), were the top-valuated features to include in patient portals for HIV prevention. Discussing HIV test results was significantly associated with an increased odds of being willing to disclose online test results with both main (adjusted odds ratio (AOR) 6.35; 95% confidence interval (CI) 2.95, 13.7) and non-main partners (AOR 3.45; 95% CI 1.59, 6.40).

Conclusions:

This study provides guidance on how patient portals may be utilized as tools for STI/HIV prevention for SMM. Future studies should consider past HIV test results discussion behavior with partners when tailoring interventions that leverage patient portals in disclosure events. Clinical Trial: N/A


 Citation

Please cite as:

Jackman KMP, Tilchin C, Duchen J, Flinn RE, Trent ME, Latkin CA, Ruhs S, Fields EL, Hamill MM, Mahaffey C, Greenbaum A, Jennings JM

Desires for Individual- and Interpersonal-Level Patient Portal Use for HIV Prevention Among Urban Sexual Minority Men: Cross-sectional Study

JMIR Form Res 2023;7:e43550

DOI: 10.2196/43550

PMID: 36826983

PMCID: 9994643

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.